Treatment options following surgery for MO encompass etidronate disodium, which inhibits crystal growth and calcification but carries a risk of osteomalacia; nonsteroidal anti-inflammatory drugs to prevent pre-osteoblast differentiation; low-dose radiation to inhibit the transformation of mesenchymal cells into osteoblasts; ascorbic acid to reduce procollagen type III synthesis; steroid injections for which there is still limited evidence; and warfarin, which reduces the production of osteocalcin [5,9]. Here, BGLAP is linked to osteomalacia.